Clinical Pharmacology & Therapeutics Associate Editors Drs. Amita Joshi and Karthik Venkatakrishnan join CPT Editor-in-Chief Dr. Piet van der Graaf to discuss the journal’s latest Call for Papers: Innovations in Clinical Pharmacology and Therapeutics. The editors discuss choosing to focus on clinical innovations in 2025, manuscript types and topics, and other exciting upcoming research from CPT.
Clinical Pharmacology & Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled “Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.” Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Rebecca Miksad, and Guest Editor Dr. Sebastian Schneeweiss to discuss the relevance of this theme in today’s clin pharm landscape as well as what types of submissions they’d most like to receive. If you have questions about submitting for this pharmacoepidemiology-themed issue, please contact Deputy Managing Editor Alaina Webster at [email protected].
Interested in learning more about the ASCPT Journal Family’s Editor-in-Training (EIT) program? Listen as current EITs Drs. Jane Knöchel and Zachary Taylor, along with former EIT and current Clinical and Translational Science Associate Editor Dr. Brian Ferslew, share their experiences with the program. Applications for the 6th EIT cohort are being accepted through June 20, 2024. If you have any questions about the program or applying, please contact Deputy Managing Editor Alaina Webster at [email protected].
Clinical Pharmacology & Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If you have questions about submitting papers for this themed issue, please contact Managing Editor Aletha Gerding at [email protected].
Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT website, so if you haven’t had a chance to watch it, you can do so. You can also read Drs. van Haarst’s and Paglialunga’s paper, which published in Clinical Pharmacology & Therapeutics, here.
